A recent study suggests that patients who stop using popular weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who stop conventional lifestyle plans.
Published data in a major medical journal demonstrates that while overweight people frequently drop substantial amounts of their total mass while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month once they quit.
"Users using such drugs should be aware of the risk of fast weight regain when the therapy concludes," cautioned expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to pre-treatment weight in about 18 months.
Weighing Treatments
The study, which looked at dozens of trials involving over 9,000 of patients, compared the results of the injectable medications with conventional dieting.
The team note that individuals who shed pounds through dieting typically experience a less rapid weight regain—approximately 100 grams monthly—post-intervention.
The Reason for the Rapid Rebound
Nutrition scientists propose the mechanism of the injections is key to understanding the accelerated rebound.
The injections imitate a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' means hunger is uncontrolled, making binge eating a significant risk."
A Chronic Issue?
Health authorities suggest the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Professionals argue that, given the significant potential of weight regain, the treatment is often life-long.
This perspective is echoed by pharmaceutical companies, who say that the findings "underscore the persistent character of obesity," comparing it to managing conditions like high blood pressure.
User Testimonies
Individuals who have stopped the medication report a intense return of cravings.
"I experienced something that goes on and you become starving," recalled one woman.
This challenge is compounded if individuals have not adopted permanent lifestyle or habit changes during treatment.
Growing Adoption
Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Adoption is greater among women compared to men.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Finally, experts stress that while GLP-1 drugs are potent agents for weight loss, they are not a standalone fix and lasting health benefits hinges on integrated behavioural management.
